Connor, Clark & Lunn Investment Management (CC&L)
AIMT

Connor, Clark & Lunn Investment Management (CC&L)’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AIMT Stock Details AIMT Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,814
Closed -$590K – 889
2017
Q3 		$590K Sell
23,814
-20,511
-46% -$508K ﹤0.01% 612
2017
Q2 		$911K Buy
44,325
+34,525
+352% +$710K 0.01% 514
2017
Q1 		$213K Buy
+9,800
New +$213K ﹤0.01% 792